Global Pharmaceutical Analytical Testing Market 2022-2028

December 2022 | 65 pages | ID: G2B719CC4CBEEN
Gen Consulting Company

Abstracts

According to Gen Consulting Company, the global pharmaceutical analytical testing market is set to achieve an incremental growth of USD 3.5 billion, acelerating at a CAGR of almost 6.8% during the forecast period 2022-2028.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global pharmaceutical analytical testing market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the pharmaceutical analytical testing industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, and region. The global market for pharmaceutical analytical testing can be segmented by type: bioanalytical testing, method development and validation, stability testing, drug substances testing, others. The bioanalytical testing segment captured the largest share of the market in 2021. Pharmaceutical analytical testing market is further segmented by region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global pharmaceutical analytical testing market in 2021 and is anticipated to hold its share during the forecast period.

Market Segmentation

By type: bioanalytical testing, method development and validation, stability testing, drug substances testing, others

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides a detailed analysis of several leading pharmaceutical analytical testing market vendors that include Eurofins Scientific SE, Laboratory Testing Inc., SGS SA, Steris plc, Tentamus Group Ltd., West Pharmaceutical Services Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global pharmaceutical analytical testing market.
• To classify and forecast the global pharmaceutical analytical testing market based on type, region.
• To identify drivers and challenges for the global pharmaceutical analytical testing market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global pharmaceutical analytical testing market.
• To identify and analyze the profile of leading players operating in the global pharmaceutical analytical testing market.

Why Choose This Report

• Gain a reliable outlook of the global pharmaceutical analytical testing market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY TYPE

Bioanalytical testing
Method development and validation
Stability testing
Drug substances testing
Others

PART 6. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 7. KEY COMPANIES

Eurofins Scientific SE
Laboratory Testing Inc.
SGS SA
Steris plc
Tentamus Group Ltd.
West Pharmaceutical Services Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER